MicroRNA 5001 (MIR5001)

MicroRNA 5001 (MIR5001) is a non-coding RNA molecule classified as a microRNA (miRNA), typically ~20–24 nucleotides in length, involved in post-transcriptional regulation of gene expression by targeting messenger RNAs (mRNAs), affecting their stability and translation. MIR5001 is linked in genomic databases (HGNC:43462, NCBI Gene:100847037) and may be associated with diseases such as familial spinal neurofibromatosis. As with other miRNAs, it is processed through the canonical Drosha/Dicer-dependent miRNA maturation pathway and is predicted to function by incorporation into the RNA-induced silencing complex (RISC) to mediate gene silencing[1][5]. Key clarifications: - There is no evidence in current scientific or pharmacological databases that MIR5001 is a recognized therapeutic target such as a receptor, enzyme, or transporter. It is classified as a gene regulatory RNA, not a direct drug target or receptor[1][5]. - No known drugs interact directly with MIR5001, nor are there established mechanisms of action or safety concerns specific to MIR5001 as a pharmacological target[1][5]. - Information about its specific biological targets, functions beyond general miRNA activity, or disease associations remains limited and may represent incomplete curation or insufficient experimental validation[1]. - The term "microRNA 5001" is valid as a gene/RNA name but does not correspond to a classical 'target' in the therapeutic sense, so the 'is_target' field is set to false, and 'is_incorrect' is set to true for purposes that expect a receptor or conventional drug target. Note: "MicroRNA 5001" is a valid miRNA gene, but not a therapeutic target according to current criteria[1][5].

Other names

hsa-mir-5001mir-5001MIR5001